These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18622161)
1. Therapy of ulcerative colitis: state of the art. Brain O; Travis SP Curr Opin Gastroenterol; 2008 Jul; 24(4):469-74. PubMed ID: 18622161 [TBL] [Abstract][Full Text] [Related]
2. Mesalamine with MMX technology for the treatment of ulcerative colitis. Schreiber S; Kamm MA; Lichtenstein GR Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380 [TBL] [Abstract][Full Text] [Related]
3. Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis. Ng SC; Kamm MA Aliment Pharmacol Ther; 2008 Oct; 28(7):815-29. PubMed ID: 18627362 [TBL] [Abstract][Full Text] [Related]
4. Review article: the management of steroid dependency in ulcerative colitis. Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of drugs for ulcerative colitis. Rosenberg LN; Peppercorn MA Expert Opin Drug Saf; 2010 Jul; 9(4):573-92. PubMed ID: 20377475 [TBL] [Abstract][Full Text] [Related]
6. Review article: the management of mild to severe acute ulcerative colitis. Travis SP Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901 [TBL] [Abstract][Full Text] [Related]
7. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids. Yamamoto-Furusho JK; Uzcanga LF Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257 [TBL] [Abstract][Full Text] [Related]
8. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up. Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440 [TBL] [Abstract][Full Text] [Related]
9. The role of endoscopic assessment in ulcerative colitis in the era of infliximab. Daperno M; Sostegni R; Pera A; Rognone D; Rigazio C; Ercole E; CrocellĂ L; Lavagna A; Rocca R Dig Liver Dis; 2008 Jul; 40 Suppl 2():S220-4. PubMed ID: 18598992 [TBL] [Abstract][Full Text] [Related]
10. Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates. Osterman MT; Lichtenstein GR Methods Find Exp Clin Pharmacol; 2009; 31(1):41-6. PubMed ID: 19357797 [TBL] [Abstract][Full Text] [Related]
11. Current management of severe ulcerative colitis. Caprilli R; Viscido A; Latella G Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544 [TBL] [Abstract][Full Text] [Related]
12. Management of acute severe ulcerative colitis. Doherty GA; Cheifetz AS Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626 [TBL] [Abstract][Full Text] [Related]
19. Clinical practice in the management of ulcerative colitis--an Italian survey. Fries W; Costa S; Costantino G; Familiari L Dig Liver Dis; 2008 Jul; 40 Suppl 2():S214-9. PubMed ID: 18598991 [TBL] [Abstract][Full Text] [Related]
20. Biologic therapy in Crohn's disease: state of the art. Jones J; Panaccione R Curr Opin Gastroenterol; 2008 Jul; 24(4):475-81. PubMed ID: 18622162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]